 Alterations endocardial vascular resistance reperfusion low flow high demand model ischemia effects dipyridamole platelet-activating factor antagonist alterations regional coronary vascular resistance type myocardial ischemia present severe angina pectoris regional perfusion function conscious dogs stenosis severe hypokinesia perfused segment left anterior coronary artery episodes min high demand ischemia atrial pacing rate sufficient dyskinesia hypoperfused segment reperfusion dogs treatment groups control dipyridamole antagonist effects endogenous platelet-activating factor stenosis residual endocardial blood flow ischemic nonnecrotic area ml/min control dipyridamole groups hours reperfusion endocardial blood flow ischemic area control dogs ml/min dogs ml/min dipyridamole ml/min control dogs endocardial coronary vascular resistance ischemic area reperfusion mm Hg/ contrast coronary vascular resistance ischemic area unchanged dogs mm Hg/ NS dogs dipyridamole mm Hg/ Regional function groups data low flow high demand ischemia induces alterations subendocardial microvasculature Such alterations regional coronary vascular resistance role several forms ischemic heart disease severe angina susceptible improvement therapeutic interventions granulocyte platelet activation